60 Degrees Pharmaceuticals, Inc. filed a registration statement with the Securities and Exchange Commission on July 17, 2025.
5 reports, 2 independent
Updated 00:00
Still developing
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
60 Degrees Pharmaceuticals, Inc. filed a registration statement with the Securities and Exchange Commission on July 17, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.The company was listed on the stock exchange and received FDA approval for its product.1 source
60 Degrees Pharmaceuticals, Inc. filed a registration statement with the SEC.1 source
Keep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- BioTech filed a registration statement with the Securities and Exchange Commission on October 7, 2026.
- flyExclusive, Inc. filed its Form 10-Q with the Securities and Exchange Commission.
- Quince Therapeutics plans to file its financial results with the Securities and Exchange Commission.
- Iron Horse Acquisitions II Corp. filed disclosures with the Securities and Exchange Commission on September 14, 2026.
- Prospect Capital Corporation expects to file a report with the Securities and Exchange Commission.
Coverage
Newest first; wire copies grouped- tickerreport.com
- GlobeNewswire60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering $5 million received upfront with up to an additional $5 million of potential aggregate gross proceeds upon the exerci
- GlobeNewswire60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering $5 million upfront with up to an additional $5 million of potential aggregate gross proceeds upon the exercise in ful